These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29849128)

  • 1. Co-inhibition of Pol η and ATR sensitizes cisplatin-resistant non-small cell lung cancer cells to cisplatin by impeding DNA damage repair.
    Li XQ; Ren J; Chen P; Chen YJ; Wu M; Wu Y; Chen K; Li J
    Acta Pharmacol Sin; 2018 Aug; 39(8):1359-1372. PubMed ID: 29849128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
    Jiang HG; Chen P; Su JY; Wu M; Qian H; Wang Y; Li J
    J Cell Physiol; 2017 Dec; 232(12):3433-3443. PubMed ID: 28075014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival.
    Dai CH; Chen P; Li J; Lan T; Chen YC; Qian H; Chen K; Li MY
    Oncotarget; 2016 Oct; 7(40):65157-65170. PubMed ID: 27533083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin.
    Inoue A; Kikuchi S; Hishiki A; Shao Y; Heath R; Evison BJ; Actis M; Canman CE; Hashimoto H; Fujii N
    J Biol Chem; 2014 Mar; 289(10):7109-7120. PubMed ID: 24474685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
    Albertella MR; Green CM; Lehmann AR; O'Connor MJ
    Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of DNA translesion synthesis polymerase η in head and neck squamous cell cancer predicts resistance to gemcitabine and cisplatin-based chemotherapy.
    Zhou W; Chen YW; Liu X; Chu P; Loria S; Wang Y; Yen Y; Chou KM
    PLoS One; 2013; 8(12):e83978. PubMed ID: 24376779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation.
    Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM
    Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
    Vendetti FP; Lau A; Schamus S; Conrads TP; O'Connor MJ; Bakkenist CJ
    Oncotarget; 2015 Dec; 6(42):44289-305. PubMed ID: 26517239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
    Chen P; Li J; Chen YC; Qian H; Chen YJ; Su JY; Wu M; Lan T
    Cell Oncol (Dordr); 2016 Dec; 39(6):511-522. PubMed ID: 27473273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired DNA double-strand breaks repair by kinesin family member 4A inhibition renders human H1299 non-small-cell lung cancer cells sensitive to cisplatin.
    Wan Q; Shen Y; Zhao H; Wang B; Zhao L; Zhang Y; Bu X; Wan M; Shen C
    J Cell Physiol; 2019 Jul; 234(7):10360-10371. PubMed ID: 30417376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
    Spanswick VJ; Lowe HL; Newton C; Bingham JP; Bagnobianchi A; Kiakos K; Craddock C; Ledermann JA; Hochhauser D; Hartley JA
    BMC Cancer; 2012 Sep; 12():436. PubMed ID: 23020514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
    Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G
    Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human DNA polymerase eta activity and translocation is regulated by phosphorylation.
    Chen YW; Cleaver JE; Hatahet Z; Honkanen RE; Chang JY; Yen Y; Chou KM
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16578-83. PubMed ID: 18946034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PANDAR promoted radiation and cisplatin-induced DNA damage repair through ATR/CHK1 in NSCLC.
    Zhao S; Yu N; Wang H; Wan Z; Diao C; Chen Y; Liu T; Yang Y; Gao F; Bai C; Cao K; Cai J
    J Gene Med; 2023 Dec; 25(12):e3565. PubMed ID: 37460393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PolH Transcript with a Short 3'UTR Enhances PolH Expression and Mediates Cisplatin Resistance.
    Zhang J; Sun W; Ren C; Kong X; Yan W; Chen X
    Cancer Res; 2019 Jul; 79(14):3714-3724. PubMed ID: 31064846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translesion DNA synthesis polymerases in DNA interstrand crosslink repair.
    Ho TV; Schärer OD
    Environ Mol Mutagen; 2010 Jul; 51(6):552-66. PubMed ID: 20658647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of genetic markers on survival in non-small cell lung cancer.
    Rosell R; Taron M; Camps C; López-Vivanco G
    Drugs Today (Barc); 2003 Oct; 39(10):775-86. PubMed ID: 14668933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
    Haynes B; Gajan A; Nangia-Makker P; Shekhar MP
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATR kinase inhibition sensitizes quiescent human cells to the lethal effects of cisplatin but increases mutagenesis.
    Hutcherson RJ; Kemp MG
    Mutat Res; 2019 Nov; 816-818():111678. PubMed ID: 31557599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisite SUMOylation restrains DNA polymerase η interactions with DNA damage sites.
    Guérillon C; Smedegaard S; Hendriks IA; Nielsen ML; Mailand N
    J Biol Chem; 2020 Jun; 295(25):8350-8362. PubMed ID: 32350109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.